(S)-(+)-2-Chlorophenylglycine methyl ester tartrate

CAS : 141109-14-0

Ref. 3D-FC33771

Informations sur le produit

• Nom: (S)-(+)-2-Chlorophenylglycine methyl ester tartrate
• Synonymes: (+)-(S)-Methyl α-amino-α-(2-chlorophenyl)acetate, (S)-(+)-2-Chlorophenylglycine methyl ester, (S)-(+)-2-chlorophenylglycine methylester tartrate, (S)-(+)-Ortho Chloro Phenyl Glycine methyl ester HCL, (S)-Methyl 2-(o-chlorophenyl)glycinate, Benzeneacetic acid, α-amino-2-chloro-, methyl ester, (+)-, Benzeneacetic acid, α-amino-2-chloro-, methyl ester, (αS)-, L(+)-2-Chlorophenylglycine Methyl HCL, Methyl (2S)-(+)-amino(2-chlorophenyl)acetate, Methyl (S)-2-amino-2-(2-chlorophenyl)acetate, Methyl (αS)-α-amino-2-chlorobenzeneacetate, Methyl 2-Amino-2-(2-Chlorophenyl)Acetate, Methyl(+)-Alpha Amino(2-Chlorophenyl) Acetate, S-(+)-2-chlorophenyl glycine methyl ester hydrochloride, methyl (2S)-amino(2-chlorophenyl)ethanoate, methyl N-(2-chlorophenyl)glycinate, s(+)-2-Chlorophenylglycine methylester tarterate

Description

(S)-(+)-2-Chlorophenylglycine methyl ester tartrate is a racemic mixture of the two enantiomers of 2-chlorophenylglycine methyl ester. The drug has been shown to be an anticoagulant that inhibits platelet aggregation and prolongs bleeding time. It is metabolized in vivo to form active metabolites, which irreversibly inhibit platelet activation by blocking the P2Y12 receptor. (S)-(+)-2-Chlorophenylglycine methyl ester tartrate is a prodrug that is converted into its active form after ingestion. The drug was originally synthesized as a potential antiplatelet agent for patients on clopidogrel therapy, but it was found to have broader utility as an anticoagulant.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 349.72 g/mol
• Formule: C₉H₁₀ClNO₂·C₄H₆O₆
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder